Affinity Asset Advisors »

Korro Bio shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Korro Bio (KRRO) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Korro Bio

Tip: Access up to 7 years of quarterly data

All positions including Korro Bio held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Korro Bio by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.0M 707k 11.32

More positions owned by Affinity Asset Advisors

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Apogee Therapeutics (APGE)
Xenon Pharmaceuticals (XENE)
Erasca (ERAS)
Insmed Com Par $.01 (INSM)
Roivant Sciences SHS (ROIV)
Spyre Therapeutics Com New (SYRE)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Praxis Precision Medicines I Com New (PRAX)
Anaptysbio Inc Common (ANAB)
Alkermes SHS (ALKS)
Cytokinetics Com New (CYTK)
Abivax Sa Sponsored Ads (ABVX)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Arcellx Common Stock (ACLX)

View all positions for Affinity Asset Advisors

Top funds holding Korro Bio

Lynx1 Capital Management
NEA Management Company
Atlas Venture Life Science Advisors
Balyasny Asset Management
VR Adviser
Affinity Asset Advisors
Nantahala Capital Management
ADAR1 Capital Management
Vanguard Group
BlackRock
Driehaus Capital Management
TCG Crossover Management
Siren
Vanguard Capital Management
72 Investment Holdings

View all funds holding Korro Bio